Patent classifications
C07F9/5045
Synthesis and Antimicrobial Uses of Dinuclear Silver(I) Pyrazolates
Novel dinuclear silver(I) pyrazolido complexes and methods of synthesizing them are provided. Advantageously, the novel silver(I) pyrazolido complexes have excellent antimicrobial activity and methods of using said complexes to treat bacterial, fungal, and viral infections are also provided.
Fluorinated N2-phosphinyl amidine compounds, chromium salt complexes, catalyst systems, and their use to oligomerize ethylene
A composition comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00001## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6. A process comprising a) contacting i) ethylene, and ii) a catalyst system comprising an N.sup.2-phosphinylamidine chromium salt complex having Structure FNPACr I: ##STR00002## wherein CrX.sub.p is a chromium salt where X is a monoanion and p is an integer from 2 to 6; and b) forming an oligomer product in a reaction zone.
Organic magnesium phosphide and manufacturing method thereof, organic magnesium phosphide complex and manufacturing method thereof, and manufacturing method of organic phosphorus compound using said phosphide
An organic magnesium phosphide expressed by Formula (1) below and an organic magnesium phosphide complex expressed by Formula (9) below are provided, and a manufacturing method of organic phosphorus compound is characterized in that the above compounds used as a reagent is reacted with an electrophile: ##STR00001##
wherein R.sup.1 and R.sup.2 are each independently an aliphatic group, heteroaliphatic group, alicyclic group, or heterocyclic group, and X is chlorine, bromine, or iodine, ##STR00002##
wherein R.sup.3 and R.sup.4 are each independently an aliphatic group, heteroaliphatic group, aromatic group, alicyclic group, or heterocyclic group, and X and Y are each independently chlorine, bromine, or iodine.
Two-component anti-cancer composition
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by Au(I) ion coordinating to dithiocarbamte ligands are connected by Au(I)-Au(I) interactions within the gold(I) dithiocarbamate polymers. Also disclosed are methods of synthesis, pharmaceutical compositions incorporating the gold(I) complexes, pharmaceutical compositions incorporating the gold(I) dithiocarbamate polymers, and methods of treating cancer.
Method of treating cancer with a two-component anti-cancer composition
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by Au(I) ion coordinating to dithiocarbamate ligands are connected by Au(I)Au(I) interactions within the gold(I) dithiocarbamate polymers. Also disclosed are methods of synthesis, pharmaceutical compositions incorporating the gold(I) complexes, pharmaceutical compositions incorporating the gold(I) dithiocarbamate polymers, and methods of treating cancer.
Organic electroluminescent materials and devices
The present invention includes novel polycyclic alkyl amino carbenes as ligands for metal complexes. These compounds may be useful as emitter materials for phosphorescent electroluminescent devices.
Vanadium alkylidene complex, synthesis and use thereof
The subject invention provides catalytical compounds/complexes, compositions comprising such compound/complex, synthesis of the compounds/complexes, and methods of using such compounds/complexes as catalysts in, for example, RCM reactions. Specifically, the subject invention provides the synthesis of the first catalytically active V oxo alkylidene, VO(CHSiMe.sub.3)(PEt.sub.3).sub.2Cl, which exhibits superior performance compared to other analogs.
First-row transition metal hydrogenation and hydrosilylation catalysts
Transition metal compounds, and specifically transition metal compounds having a tetradentate and/or pentadentate supporting ligand are described, together with methods for the preparation thereof and the use of such compounds as hydrogenation and/or hydrosilylation catalysts.
METAL COMPLEX AND METHOD FOR PRODUCING THE SAME, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE METAL COMPLEX, AND METHODS FOR PRODUCING ?-OLEFIN POLYMER AND COPOLYMER USING THE CATALYST FOR OLEFIN POLYMERIZATION
Provided are a novel catalyst component for producing an -olefin (co)polymer, and a production method using the same. A metal complex is obtainable by contacting a compound represented by the general formula [I] or [II] with a transition metal compound containing a transition metal belonging to 9th to 11th group:
##STR00001##
wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 represent (i) hydrogen, (ii) a halogen, (iii) a linear alkyl or the like, or (iv) OR.sup.9 or the like; R.sup.5 and R.sup.6 represent a linear alkyl group or the like; any one of R.sup.1-R.sup.6 may have a heteroatom or a heteroatom containing group; E.sup.1 represents phosphorus, arsenic or antimony; X.sup.1 represents oxygen or sulfur; Z represents hydrogen or a leaving group.
TWO-COMPONENT ANTI-CANCER COMPOSITION
Gold(I) complexes and gold(I) dithiocarbamate polymers as anticancer therapeutics. The Au(I) ion within the gold(I) complexes is coordinated to two phosphine ligands. The repeating unit formed by Au(I) ion coordinating to dithiocarbamte ligands are connected by Au(I)-Au(I) interactions within the gold(I) dithiocarbamate polymers. Also disclosed are methods of synthesis, pharmaceutical compositions incorporating the gold(I) complexes, pharmaceutical compositions incorporating the gold(I) dithiocarbamate polymers, and methods of treating cancer.